Atlas Trials

Ralf Rothoerl

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ralf Rothoerl

RecordFirmDate
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate. (NCT06705023)Ralf Rothoerl2024-11-18

Track Ralf Rothoerl automatically

Every clearance here is in the API, with alerts when new ones post.